世界の非びらん性胃食道逆流症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nonerosive Reflux Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5889
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、非びらん性胃食道逆流症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトンポンプ阻害剤、H2受容体拮抗薬、制酸剤、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・非びらん性胃食道逆流症治療の市場動向
・企業の競争状況、市場シェア
・非びらん性胃食道逆流症治療の種類別市場規模と予測2016-2027（プロトンポンプ阻害剤、H2受容体拮抗薬、制酸剤、その他）
・非びらん性胃食道逆流症治療の用途別市場規模と予測2016-2027（小売薬局、病院薬局、オンライン薬局）
・非びらん性胃食道逆流症治療の北米市場規模2016-2027（アメリカ、カナダ）
・非びらん性胃食道逆流症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・非びらん性胃食道逆流症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・非びらん性胃食道逆流症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・非びらん性胃食道逆流症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Eisai、GlaxoSmithKline、Takeda Pharmaceutical、Johnson & Johnson、Daewoong Pharmaceutical、Ironwood Pharmaceuticals、SRS Pharmaceuticals、SFJ Pharmaceuticals Group）
・結論

Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD).

Market Analysis and Insights: Global Nonerosive Reflux Disease Treatment Market
The global Nonerosive Reflux Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonerosive Reflux Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonerosive Reflux Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonerosive Reflux Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonerosive Reflux Disease Treatment market.

Global Nonerosive Reflux Disease Treatment Scope and Market Size
Nonerosive Reflux Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nonerosive Reflux Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Proton pump inhibitors
H2 Receptor Antagonists
Antacids
Others

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eisai
GlaxoSmithKline
Takeda Pharmaceutical
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
SRS Pharmaceuticals
SFJ Pharmaceuticals Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Proton pump inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Antacids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nonerosive Reflux Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nonerosive Reflux Disease Treatment Market Perspective (2016-2027)
2.2 Nonerosive Reflux Disease Treatment Growth Trends by Regions
2.2.1 Nonerosive Reflux Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nonerosive Reflux Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Nonerosive Reflux Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Nonerosive Reflux Disease Treatment Industry Dynamic
2.3.1 Nonerosive Reflux Disease Treatment Market Trends
2.3.2 Nonerosive Reflux Disease Treatment Market Drivers
2.3.3 Nonerosive Reflux Disease Treatment Market Challenges
2.3.4 Nonerosive Reflux Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nonerosive Reflux Disease Treatment Players by Revenue
3.1.1 Global Top Nonerosive Reflux Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Nonerosive Reflux Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Nonerosive Reflux Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nonerosive Reflux Disease Treatment Revenue
3.4 Global Nonerosive Reflux Disease Treatment Market Concentration Ratio
3.4.1 Global Nonerosive Reflux Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonerosive Reflux Disease Treatment Revenue in 2020
3.5 Nonerosive Reflux Disease Treatment Key Players Head office and Area Served
3.6 Key Players Nonerosive Reflux Disease Treatment Product Solution and Service
3.7 Date of Enter into Nonerosive Reflux Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nonerosive Reflux Disease Treatment Breakdown Data by Type
4.1 Global Nonerosive Reflux Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Nonerosive Reflux Disease Treatment Breakdown Data by Application
5.1 Global Nonerosive Reflux Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nonerosive Reflux Disease Treatment Market Size (2016-2027)
6.2 North America Nonerosive Reflux Disease Treatment Market Size by Type
6.2.1 North America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2027)
6.3 North America Nonerosive Reflux Disease Treatment Market Size by Application
6.3.1 North America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2027)
6.4 North America Nonerosive Reflux Disease Treatment Market Size by Country
6.4.1 North America Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nonerosive Reflux Disease Treatment Market Size (2016-2027)
7.2 Europe Nonerosive Reflux Disease Treatment Market Size by Type
7.2.1 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Nonerosive Reflux Disease Treatment Market Size by Application
7.3.1 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Nonerosive Reflux Disease Treatment Market Size by Country
7.4.1 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nonerosive Reflux Disease Treatment Market Size (2016-2027)
9.2 Latin America Nonerosive Reflux Disease Treatment Market Size by Type
9.2.1 Latin America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Nonerosive Reflux Disease Treatment Market Size by Application
9.3.1 Latin America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Nonerosive Reflux Disease Treatment Market Size by Country
9.4.1 Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nonerosive Reflux Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Nonerosive Reflux Disease Treatment Introduction
11.2.4 Eisai Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Details
11.4.2 Takeda Pharmaceutical Business Overview
11.4.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Introduction
11.4.4 Takeda Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.4.5 Takeda Pharmaceutical Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Details
11.6.2 Daewoong Pharmaceutical Business Overview
11.6.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Introduction
11.6.4 Daewoong Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Details
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.7.5 Ironwood Pharmaceuticals Recent Development
11.8 SRS Pharmaceuticals
11.8.1 SRS Pharmaceuticals Company Details
11.8.2 SRS Pharmaceuticals Business Overview
11.8.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Introduction
11.8.4 SRS Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.8.5 SRS Pharmaceuticals Recent Development
11.9 SFJ Pharmaceuticals Group
11.9.1 SFJ Pharmaceuticals Group Company Details
11.9.2 SFJ Pharmaceuticals Group Business Overview
11.9.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Introduction
11.9.4 SFJ Pharmaceuticals Group Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021)
11.9.5 SFJ Pharmaceuticals Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Proton pump inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Antacids
Table 5. Key Players of Others
Table 6. Global Nonerosive Reflux Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nonerosive Reflux Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nonerosive Reflux Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Nonerosive Reflux Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Nonerosive Reflux Disease Treatment Market Share by Regions (2022-2027)
Table 12. Nonerosive Reflux Disease Treatment Market Trends
Table 13. Nonerosive Reflux Disease Treatment Market Drivers
Table 14. Nonerosive Reflux Disease Treatment Market Challenges
Table 15. Nonerosive Reflux Disease Treatment Market Restraints
Table 16. Global Nonerosive Reflux Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Nonerosive Reflux Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2020)
Table 19. Ranking of Global Top Nonerosive Reflux Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Nonerosive Reflux Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nonerosive Reflux Disease Treatment Product Solution and Service
Table 23. Date of Enter into Nonerosive Reflux Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Nonerosive Reflux Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Nonerosive Reflux Disease Treatment Product
Table 66. AstraZeneca Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Eisai Company Details
Table 69. Eisai Business Overview
Table 70. Eisai Nonerosive Reflux Disease Treatment Product
Table 71. Eisai Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Eisai Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product
Table 76. GlaxoSmithKline Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Takeda Pharmaceutical Company Details
Table 79. Takeda Pharmaceutical Business Overview
Table 80. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 81. Takeda Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Takeda Pharmaceutical Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Nonerosive Reflux Disease Treatment Product
Table 86. Johnson & Johnson Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Daewoong Pharmaceutical Company Details
Table 89. Daewoong Pharmaceutical Business Overview
Table 90. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 91. Daewoong Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Daewoong Pharmaceutical Recent Development
Table 93. Ironwood Pharmaceuticals Company Details
Table 94. Ironwood Pharmaceuticals Business Overview
Table 95. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product
Table 96. Ironwood Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Ironwood Pharmaceuticals Recent Development
Table 98. SRS Pharmaceuticals Company Details
Table 99. SRS Pharmaceuticals Business Overview
Table 100. SRS Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. SRS Pharmaceuticals Recent Development
Table 102. SFJ Pharmaceuticals Group Company Details
Table 103. SFJ Pharmaceuticals Group Business Overview
Table 104. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product
Table 105. SFJ Pharmaceuticals Group Revenue in Nonerosive Reflux Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. SFJ Pharmaceuticals Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonerosive Reflux Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Proton pump inhibitors Features
Figure 3. H2 Receptor Antagonists Features
Figure 4. Antacids Features
Figure 5. Others Features
Figure 6. Global Nonerosive Reflux Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Retail Pharmacies Case Studies
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Nonerosive Reflux Disease Treatment Report Years Considered
Figure 11. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Nonerosive Reflux Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Nonerosive Reflux Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Nonerosive Reflux Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Nonerosive Reflux Disease Treatment Revenue in 2020
Figure 18. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Nonerosive Reflux Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Nonerosive Reflux Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Nonerosive Reflux Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nonerosive Reflux Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Nonerosive Reflux Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nonerosive Reflux Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Nonerosive Reflux Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Nonerosive Reflux Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Nonerosive Reflux Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 64. Daewoong Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 65. Ironwood Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 66. SRS Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 67. SFJ Pharmaceuticals Group Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のパジェット病治療市場規模・現状・予測（2021年-2027年）

Global Paget's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4647 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、パジェット病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント）、用途別市場規模（病院、ク...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4446 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のライソゾーム病治療市場規模・現状・予測（2021年-2027年）

Global Lysosomal Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5232 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、ライソゾーム病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（造血幹細胞移植、酵素補充療法、基質減少、シャペロン療法）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主...

世界のパーキンソン病治療市場規模・現状・予測（2021年-2027年）

Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4659 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、パーキンソン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、経皮、皮下、腸内注入）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のスティル病治療市場規模・現状・予測（2021年-2027年）

Global Still’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4906 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、スティル病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場...

世界の常染色体優性多発性嚢胞腎用治療市場規模・現状・予測（2021年-2027年）

Global Autosomal Dominant Polycystic Kidney Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3879 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、常染色体優性多発性嚢胞腎用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（痛み＆炎症治療、腎臓結石治療、尿路感染症治療、腎不全治療、その他）、用途別市場規模（病院、診療所、外来手術センター、その他...

世界のスティル病治療市場規模・現状・予測（2021年-2027年） Still’s disease is a rare rheumatic condition. This condition is characterized by biological and clinical symptoms such as high spiking fever, joint swelling, muscle pain, sore throat, increased number of white cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for still…
世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market The global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is projected to reach US$ 16110 million by 2027, from US$ 12890 million in 2020, at a CAGR of 2.8% during 2021-2027. With i…
世界のバッテン病治療市場規模・現状・予測（2021年-2027年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Market Analysis and Insights: Global Batten Disease Treatment Market The global Batte…